Equifax CEO exercises options, sells 37,791 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Equifax CEO Mark W. Begor exercised stock options covering 37,791 shares of common stock at an exercise price of $112.46 per share on 2026-07-24, then sold 37,791 shares in multiple transactions at reported weighted-average prices including $175.8520, $169.8583 and $171.2619 per share, pursuant to a Rule 10b5-1 trading plan adopted on 10/28/2025. He reports 37,792 stock options remaining and additional indirect common stock holdings through several 2-year GRATs.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option/Right to Buy F1, F11 | 37,791 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 37,791 | $112.46 | $4.25M |
| Sale | Common Stock F1, F3, F2 | 500 | $175.852 | $88K |
| Sale | Common Stock F1, F4, F2 | 600 | $169.8583 | $102K |
| Sale | Common Stock F1, F5, F2 | 600 | $168.4747 | $101K |
| Sale | Common Stock F1, F6, F2 | 1,300 | $174.9123 | $227K |
| Sale | Common Stock F1, F7, F2 | 2,936 | $173.7877 | $510K |
| Sale | Common Stock F1, F8, F2 | 4,112 | $172.79 | $711K |
| Sale | Common Stock F1, F9, F2 | 6,200 | $171.2619 | $1.06M |
| Sale | Common Stock F1, F10, F2 | 21,543 | $171.9986 | $3.71M |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (11)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.
- F2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
- F3. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $175.74 to $175.94, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F4. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $169.42 to $170.09, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F5. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $168.395 to $168.55, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F6. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $174.54 to $175.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F7. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $173.50 to $174.15, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F8. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $172.50 to $173.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F9. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $170.48 to $171.47, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F10. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $171.50 to $172.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F11. The option vested in three equal annual increments beginning 5/4/2019.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
dividend equivalent units financial
restricted stock units financial
GRAT financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Equifax (EFX) CEO Mark Begor report on 2026-07-24?
What stock options did Equifax (EFX) CEO Mark Begor exercise?
What indirect Equifax (EFX) holdings does Mark Begor report through GRATs?
AI-generated analysis. How Rhea-AI works. Not financial advice.